Citalopram HBR 20 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB25FQJBV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,317
Award facts
- Contract value 100% obligated
- $13,316.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Citalopram HBr 20 mg tablets in quantities of 500 units, with a ceiling value of $13,316.99 and a firm fixed price structure. This is a non-set-aside contract, indicating the award was made through open competition. The delivery order is expected to be completed by August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Citalopram is a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety treatment, reflecting the broader pharmaceutical supply needs of federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Through this prime contract vehicle, AmerisourceBergen supplies a wide range of pharmaceutical products and medical commodities to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's extensive portfolio of federal awards demonstrates its established capability as a critical pharmaceutical distributor for defense and federal medical procurement, with contracts covering specialty medications, vaccines, generics, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQJBV?
SPE2DB25FQJBV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FQJBV worth?
The government has obligated $13,317 on SPE2DB25FQJBV.
Is contract SPE2DB25FQJBV an order under another contract?
Yes. SPE2DB25FQJBV is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJBV competed?
The extent of competition for SPE2DB25FQJBV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award